Back

Adjustments in furosemide dose in patients with heart faillure receiving SGLT2is-does HbA1c matter?

20 May 2023 (15:40 - 17:00)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - treatment 2 Pharmacotherapy HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Maria Stratinaki

Venizelio General Hospital, Heraklion (Greece)

5 More presentations in this session

Presentation thumbnail
Impact of early initiation of mTOR inhibitors on long-term survival outcome after heart transplantation: data from the nationwide Korean Organ Transplant Registry (KOTRY)
Professor H. Cho (Seoul, KR)
Abstract Slides
Presentation thumbnail
Kidney dysfunction correlates with worse response to levosimendan treatment
Doctor F. Gerardo (Amadora, PT)
Abstract Slides
Presentation thumbnail
Baseline characteristics and alterations after initiation of therapy with SGLT2i in a real-world heart failure with reduced ejection fraction population
Doctor A. Stavrati (Thessaloniki, GR)
Abstract Slides
Presentation thumbnail
A year in the life of diuretic usage in an outpatient heart failure unit
Doctor D. O'Flynn (Dublin, IE)
Abstract Slides
Presentation thumbnail
Long-term clinical impact of nutritional intervention in patients with acute heart failure
Assistant Professor K. Choi (Seoul, KR)
Abstract Slides

Access the full session

Session thumbnail
ePosters in chronic heart failure - treatment 2

The Event

Event poster

Heart Failure 2023

20 May 2023 15:40 CET
You may be interested in
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios
thumbnail
Congress Session
Meet the Experts: summation of the science - treatment of chronic heart failure in 2023
thumbnail
Webinar
MRAs in heart failure: what's old is new again

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources